Erste Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$203K	Hold	62,000	–	–	﹤0.01%	564
2025 Q4	$215K	Hold	62,000	–	–	﹤0.01%	545
2025 Q3	$302K	Hold	62,000	–	–	﹤0.01%	532
2025 Q2	$224K	Hold	62,000	–	–	﹤0.01%	746
2025 Q1	$143K	Hold	62,000	–	–	﹤0.01%	484
2024 Q4	$185K	Hold	62,000	–	–	﹤0.01%	487
2024 Q3	$162K	Hold	62,000	–	–	﹤0.01%	487
2024 Q2	$179K	Hold	62,000	–	–	﹤0.01%	481
2024 Q1	$278K	Hold	62,000	–	–	﹤0.01%	467
2023 Q4	$368K	Hold	62,000	–	–	0.01%	449
2023 Q3	$289K	Hold	62,000	–	–	0.01%	455
2023 Q2	$408K	Hold	62,000	–	–	0.01%	437
2023 Q1	$460K	Hold	62,000	–	–	0.01%	428
2022 Q4	$623K	Hold	62,000	–	–	0.01%	408
2022 Q3	$611K	Hold	62,000	–	–	0.01%	397
2022 Q2	$627K	Hold	62,000	–	–	0.01%	406
2022 Q1	$605K	Buy	+62,000	New	+$587K	0.01%	420